Allergan rejects US$47bn Valeant bid

The US pharmaceuticals group Allergan has rejected the unsolicited US$47bn takeover offer it received from Canada’s Valeant Pharmaceuticals International saying that the proposal “substantially undervalues” Allergan and that it “creates…